Condition: Multiple Myeloma · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to identify preventive treatments that can minimize the occurrence, severity, and duration of talquetamab-related taste changes (dysgeusia), during the prophylaxis (preventive) treatment phase, to better characterize the signs or symptoms of talquetamab-related taste changes and to better characterize the signs or symptoms of ramantamig-related taste changes.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| Colorado Blood Cancer Institute | Denver, Colorado, United States | Recruiting |
| Yale University School Of Medicine | New Haven, Connecticut, United States | Recruiting |
| Icahn School of Medicine at Mt. Sinai | New York, New York, United States | Recruiting |
| University of Rochester Medical Center | Rochester, New York, United States | Recruiting |
| Duke University Medical Center | Durham, North Carolina, United States | Recruiting |
| University Hospitals Cleveland Medical Center | Cleveland, Ohio, United States | Recruiting |
| Virginia Commonwealth University - Massey Cancer Center | Richmond, Virginia, United States | Recruiting |
| University of Washington | Seattle, Washington, United States | Recruiting |
| Hospitais Integrados da Gavea SA DF Star | Brasília, Brazil | Recruiting |
| Fundacao Universidade de Caxias do Sul | Caxias do Sul, Brazil | Recruiting |
| Hospital Erasto Gaertner- Liga Paranaense de Combate ao Cancer | Curitiba, Brazil | Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06500884